TCBP Provides Quarterly Update on the ACHIEVE (UK) Clinical Trial [Yahoo! Finance]
TC BioPharm (Holdings) plc - American Depositary Shares (TCBP)
Company Research
Source: Yahoo! Finance
EDINBURGH, Scotland Dec. 4, 2024 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced an update on the progression of the ACHIEVE UK Trial. As of this week, over half of the Cohort A patients in Stage One of the ACHIEVE study have received TCB008. These patients have an unmet clinical need, as they have been unable to attain remission with the existing Standard of Care, other treatments, or tolerate further chemotherapy. Data evaluated at this milestone demonstrate positive safety signals for the 5mL dose of TCB008, as no Serious Adverse Events have been attributed to the TCB008 drug product. The Company intends to use this data to justify further increases in the TCB008 dose, from 230 million Gamma Delta T-Cells up to 819 million Gamma Delta T-Cells, to identify the optimal dose for Cohort A patie
Show less
Read more
Impact Snapshot
Event Time:
TCBP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TCBP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TCBP alerts
High impacting TC BioPharm (Holdings) plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
TCBP
News
- TCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 PatientsPR Newswire
- TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend [Yahoo! Finance]Yahoo! Finance
- TCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder DividendPR Newswire
- EXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend [Yahoo! Finance]Yahoo! Finance
- TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell TherapyPR Newswire
TCBP
Sec Filings
- 12/17/24 - Form 6-K
- 12/16/24 - Form 424B5
- 12/16/24 - Form 6-K
- TCBP's page on the SEC website